Panacea Innovations LLC is categorized under Wholesale Pharmaceutical Products in Hightstown, NJ and active since 2006.
Panacea Innovations LLC was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Daryll Cummings at the company’s single location by writing to 7 Debbie Lane, Hightstown, New Jersey NJ 08520 or by phoning (609) 443-4603. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Panacea Innovations LLC |
| Contact Person: | Daryll Cummings |
| Address: | 7 Debbie Lane, Hightstown, New Jersey 08520 |
| Phone Number: | (609) 443-4603 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Panacea Innovations LLC was started in 2006 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daryll Cummings for inquiries that concern Panacea Innovations LLC by calling the company number (609) 443-4603, as your correspondence is most welcome. Additionally, the physical location of the single location of Panacea Innovations LLC can be found at the coordinates as well as the street address 7 Debbie Lane in Hightstown, New Jersey 08520.
For its online presence, you may visit Panacea Innovations LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.